New targets for inhibitors of HIV-1 replication, Nature Reviews Molecular Cell Biology, vol.1, issue.1, pp.40-49, 2000. ,
DOI : 10.1038/35036060
HIV and AIDS: 20 years of science, Nature Medicine, vol.9, issue.7, pp.839-843, 2003. ,
DOI : 10.1038/nm0703-839
Re-emergence of HIV after stopping therapy, Nature, vol.401, issue.6756, pp.874-875, 1999. ,
DOI : 10.1038/44755
Latent infection of CD4(+) T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy, Nature Medicine, vol.5, issue.5, pp.512-517, 1999. ,
Eliminating HIV-1 reservoirs, Curr Opin Investig Drugs, vol.3, issue.8, pp.1133-1137, 2002. ,
Can HIV be Cured? Mechanisms of HIV Persistence and Strategies to Combat It, Current HIV Research, vol.2, issue.2, pp.99-111, 2004. ,
DOI : 10.2174/1570162043484915
Latent reservoirs of HIV: obstacles to the eradication of virus. P r o c N a t l A c a d S c i U S A, pp.10958-10961, 1999. ,
HIV-1 Entry and Its Inhibition, Curr Top Microbiol Immunol, vol.281, pp.1-27, 2003. ,
DOI : 10.1007/978-3-642-19012-4_1
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens, Science, vol.280, issue.5371, pp.1884-1888, 1998. ,
DOI : 10.1126/science.280.5371.1884
Virus Attachment and Entry Offer Numerous Targets for Antiviral Therapy, Current Pharmaceutical Design, vol.10, issue.30, pp.3701-3712, 2004. ,
DOI : 10.2174/1381612043382729
Cell surface receptors, virus entry and tropism of primate lentiviruses, Journal of General Virology, vol.83, issue.8, pp.1809-1829, 2002. ,
DOI : 10.1099/0022-1317-83-8-1809
Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus, Cell, vol.50, issue.3, pp.327-328, 1987. ,
DOI : 10.1016/0092-8674(87)90485-5
Retroviral Envelope Glycoproteins Contain a "Leucine Zipper"-like Repeat, AIDS Research and Human Retroviruses, vol.6, issue.6, pp.703-706, 1990. ,
DOI : 10.1089/aid.1990.6.703
Heptad Repeat Sequences are Located Adjacent to Hydrophobic Regions in Several Types of Virus Fusion Glycoproteins, Journal of General Virology, vol.71, issue.12 ,
DOI : 10.1099/0022-1317-71-12-3075
Core Structure of gp41 from the HIV Envelope Glycoprotein, Cell, vol.89, issue.2, pp.263-273, 1997. ,
DOI : 10.1016/S0092-8674(00)80205-6
A trimeric structural domain of the HIV-1 transmembrane glycoprotein, Nature Structural Biology, vol.247, issue.12, pp.1075-1082, 1995. ,
DOI : 10.1016/0076-6879(87)54085-X
Atomic structure of a thermostable subdomain of HIV-1 gp41, Proceedings of the National Academy of Sciences, vol.289, issue.5796, pp.9412303-12308, 1997. ,
DOI : 10.1038/289366a0
Atomic structure of the ectodomain from HIV-1 gp41, Nature, vol.387, issue.6631, pp.426-430, 1997. ,
DOI : 10.1038/387426a0
Mechanisms of Viral Membrane Fusion and Its Inhibition, Annual Review of Biochemistry, vol.70, issue.1, pp.777-810, 2001. ,
DOI : 10.1146/annurev.biochem.70.1.777
The HIV Env-mediated fusion reaction, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1614, issue.1, pp.161436-50, 2003. ,
DOI : 10.1016/S0005-2736(03)00161-5
HIV Entry and Its Inhibition, Cell, vol.93, issue.5, pp.681-684, 1998. ,
DOI : 10.1016/S0092-8674(00)81430-0
Peptides Trap the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Fusion Intermediate at Two Sites, Journal of Virology, vol.77, issue.3, pp.1666-1671, 2003. ,
DOI : 10.1128/JVI.77.3.1666-1671.2003
Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides, J Virol, vol.72, issue.2, pp.986-993, 1998. ,
Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region, Proceedings of the National Academy of Sciences, vol.283, issue.5400, pp.9811187-11192, 2001. ,
DOI : 10.1126/science.283.5400.357
Protein Design of an HIV-1 Entry Inhibitor, Science, vol.291, issue.5505, pp.884-888, 2001. ,
DOI : 10.1126/science.1057453
Potent suppression of HIV-1 replication in humans by T-20, a peptide
inhibitor of gp41-mediated virus entry, Nature Medicine, vol.14, issue.11, pp.1302-1307, 1998. ,
DOI : 10.1016/S0092-8674(00)81430-0
Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection., Proceedings of the National Academy of Sciences, vol.91, issue.21, pp.919770-9774, 1994. ,
DOI : 10.1073/pnas.91.21.9770
Case history: Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes, Nature Reviews Drug Discovery, vol.3, issue.3, pp.215-225, 2004. ,
DOI : 10.1038/nrd1331
Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation, Journal of Molecular Biology, vol.295, issue.2, pp.163-168, 2000. ,
DOI : 10.1006/jmbi.1999.3368
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy, Antimicrobial Agents and Chemotherapy, vol.46, issue.6, pp.461896-1905, 2002. ,
DOI : 10.1128/AAC.46.6.1896-1905.2002
Sensitivity of Human Immunodeficiency Virus Type 1 to the Fusion Inhibitor T-20 Is Modulated by Coreceptor Specificity Defined by the V3 Loop of gp120, Journal of Virology, vol.74, issue.18, pp.748358-8367, 2000. ,
DOI : 10.1128/JVI.74.18.8358-8367.2000
Sensitivity of Human Immunodeficiency Virus Type 1 to Fusion Inhibitors Targeted to the gp41 First Heptad Repeat Involves Distinct Regions of gp41 and Is Consistently Modulated by gp120 Interactions with the Coreceptor, Journal of Virology, vol.75, issue.18, pp.758605-8614, 2001. ,
DOI : 10.1128/JVI.75.18.8605-8614.2001
CD4-Induced T-20 Binding to Human Immunodeficiency Virus Type 1 gp120 Blocks Interaction with the CXCR4 Coreceptor, Journal of Virology, vol.78, issue.10, pp.785448-5457, 2004. ,
DOI : 10.1128/JVI.78.10.5448-5457.2004
Dissociation of gp120 from HIV-1 virions induced by soluble CD4, Science, vol.250, issue.4984, pp.1139-1142, 1990. ,
DOI : 10.1126/science.2251501
Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120., Proceedings of the National Academy of Sciences, vol.88, issue.6, pp.2189-2193, 1991. ,
DOI : 10.1073/pnas.88.6.2189
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding, Journal of Experimental Medicine, vol.174, issue.2, pp.407-415, 1991. ,
DOI : 10.1084/jem.174.2.407
Role of the Ectodomain of the gp41 Transmembrane Envelope Protein of Human Immunodeficiency Virus Type 1 in Late Steps of the Membrane Fusion Process, Journal of Virology, vol.78, issue.2, pp.811-820, 2004. ,
DOI : 10.1128/JVI.78.2.811-820.2004
Capture of an early fusion-active conformation of HIV-1 gp41, Nature Structural Biology, vol.26, issue.4, pp.276-279, 1998. ,
DOI : 10.1083/jcb.140.2.315
Subdomain folding and biological activity of the core structure from human immunodeficiency virus type 1 gp41: implications for viral membrane fusion, J Virol, vol.73, issue.5, pp.4433-4438, 1999. ,
Inhibition of human immunodeficiency virus type 1 infectivity by the gp41 core: role of a conserved hydrophobic cavity in membrane fusion, J Virol, issue.10, pp.738578-8586, 1999. ,
Role of the betachemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia, J Virol, vol.72, issue.4, pp.3351-3361, 1998. ,
The Anti-HIV Pseudopeptide HB-19 Forms a Complex with the Cell-surface-expressed Nucleolin Independent of Heparan Sulfate Proteoglycans, Journal of Biological Chemistry, vol.274, issue.39, pp.27427875-27884, 1999. ,
DOI : 10.1074/jbc.274.39.27875
Different from the HIV Fusion Inhibitor C34, the Anti-HIV Drug Fuzeon (T-20) Inhibits HIV-1 Entry by Targeting Multiple Sites in gp41 and gp120, Journal of Biological Chemistry, vol.280, issue.12, pp.28011259-11273, 2005. ,
DOI : 10.1074/jbc.M411141200
Mode of Action of an Antiviral Peptide from HIV-1: INHIBITION AT A POST-LIPID MIXING STAGE, Journal of Biological Chemistry, vol.276, issue.2, pp.1391-1397, 2001. ,
DOI : 10.1074/jbc.M004113200
Dilation of the Human Immunodeficiency Virus???1 Envelope Glycoprotein Fusion Pore Revealed by the Inhibitory Action of a Synthetic Peptide from gp41, The Journal of Cell Biology, vol.15, issue.2, pp.315-323, 1998. ,
DOI : 10.1083/jcb.127.6.1885
HIV-1 Envelope Proteins Complete Their Folding into Six-helix Bundles Immediately after Fusion Pore Formation, Molecular Biology of the Cell, vol.14, issue.3, pp.926-938, 2003. ,
DOI : 10.1091/mbc.E02-09-0573
Design and properties of N(CCG)-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity ,
Change in Coreceptor Use Correlates with Disease Progression in HIV-1???Infected Individuals, The Journal of Experimental Medicine, vol.70, issue.4, pp.1114621-628 ,
DOI : 10.1038/373117a0
Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype, J Virol, vol.72, issue.1, pp.512-519, 1998. ,